CHU De Martinique — Clinical Trial Site

23 Registered trials

15 Currently recruiting

Organisation

CHU De Martinique

Location

Fort De France Cedex, France

Identifier

ORG-100044137

Address

P. O. Box 90632, 97261, France

Departments

Cardiologie
cardiology
CeGIDD
Dermatologie
endocrinology and oncology
Infectious and Tropical Diseases
Infectious diseases
Internal Medicine
médecine nucléaire
Medical Oncology
Oncologie
oncology
oncology department
Radiothérapie
Radiotherapy
Service d’Accueil des Urgences Adultes -SAMU 972

Clinical trials at this site (23)

Search interface

Extension Study of ACT-EARLY Pending

2024-513676-18-00 Transthyretin Amyloidosis 5
LEAn Body Mass Normalization of OXaliplatin Based Chemotherapy Pending

2024-515340-23-00 Colon cancer 4
Which is the best treatment to relieve severe acute pain in the prehospital phase : Morphine or alfentanil ? Pending

2025-522817-50-00 Severe pain 6
TRITON-CM: A Study to Evaluate Nucresiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy Recruiting

2024-519917-72-00 Transthyretin Amyloidosis with Cardiomyopathy (ATTR Amy 5 2025-10-29
MODULO Recruiting

2024-515793-27-01 HIV 5 2025-04-30
Randomized clinical trial to compare oral isotretinoin to standard of care in moderate acne skin of color patients Recruiting

2023-507519-36-00 Acne 5 2025-04-29
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant Recruiting

2024-513547-82-00 Transthyretin Amyloidosis 5 2025-03-11
Treatment with darolutamide +/- radiation therapy for patients with a castration resistant cancer and metastases detected by functional imag… Recruiting

2023-509787-15-00 Patients with localised prostate cancer and high-risk f 5 2025-02-17
Beta-blOckers discoNtinuation in patients presenting heart FaIlure with REcovered left ventricular ejection fraction Recruiting

2023-508798-94-00 Heart failure 5 2025-02-11
Induction therapy for lupus nephritis with no added oral corticosteroids : An open label randomised multicentre controlled trial comparing … Recruiting

2024-516242-19-00 lupus nephritis 5 2024-11-05
FIRST LINE CHEMOTHERAPY FOR METASTATIC GASTRO ENTERO PANCREATIC NEUROENDOCRINE CARCINOMA Recruiting

2024-515300-39-00 METASTATIC GRADE 3 POORLY DIFFERENTIATED NEUROENDOCRINE 4 2024-10-18
Treatment with darolutamide +/- radiation therapy for patients with a castration resistant cancer and metastases detected by functional imag… Recruiting

2023-507482-26-00 Castrate-resistant prostate cancer with oligometastases 5 2024-10-04
PRODIGE 70 - CIRCULATE - CIRCULATING TUMOR DNA BASED DECISION FOR ADJUVANT TREATMENT IN COLON CANCER STAGE II Recruiting

2024-515297-27-00 colon carcinoma 5 2024-08-14
Staphylococcus aureus Network Adaptive Platform trial (SNAP) Recruiting

2023-503582-35-00 Staphylococcus aureus bacteremia 6 2023-10-26
Randomised phase III trial of ADT +/- darolutamide in frail men with castration-naïve de novo metastatic prostate cancer Recruiting

2022-502425-18-00 Adenocarcinoma of the prostate 5 2022-04-19
Multicentre, randomized, controlled, open-label, multi-centre medicoeconomic study evaluating the efficacy of adding zoledronic acid or deno… Recruiting

2024-513248-27-00 Patients, men or women over 18 old, with inoperable ver 5 2020-07-20
Multicentric phase III trial comparing two strategies in intermediate-risk differentiated thyroid cancer patients: Systematic radioiodine ad… Recruiting

2024-514603-34-00 intermediate-risk differentiated thyroid cancer patient 5 2020-03-02
A Phase III trial of acetylsalicylic acid and atorvastatin in patients with castrate-resistant prostate cancer (PEACE 4) Recruiting

2023-508072-11-00 Castration-resistant prostate cancer 5 2019-06-26
A clinical study evaluating the benefits of apalutamide, a novel drug targeting prostate cancer growth, in combination with radiotherapy and… Ended

2024-514829-36-00 High-risk biochemically-relapsed prostate adenocarcinom 5 2019-12-02
PRODIGE 34 - ADAGE: Randomised phase III study evaluating adjuvant chemotherapy after resection of stage III colon adenocarcinoma in patient… Ended

2024-518741-21-00 colon cancer 4 2014-12-23
Cohort study of human mpox virus disease Ended

2022-501132-42-00 Monkeypox virus disease 6 2022-08-02
A randomized non-inferiority clinical trial of doxycycline vs BPG for early syphilis Ended

2024-513532-23-00 early syphilis 5 2021-12-06
A Phase 3, Randomized, Double-Blind Study of Ociperlimab, an Anti-TIGIT Antibody, in Combination With Tislelizumab Compared to Pembrolizumab… Ended

2023-507317-10-00 Locally advanced, unresectable, or metastatic non small 5 2021-05-10